I architect AI systems for evidence synthesis and clinical development at Eli Lilly — protocol-anchored screening, multimodal extraction from trial literature, and digital-twin simulation for trial design.
Current builds:
- CIPHER — evidence curation platform with deterministic screening, LLM judgment at the edges, and signed provenance
- Digital Twin AI Agent — synthetic control arm generation for single-arm trial augmentation
- BATMAN+ AI Agent — automated network meta-analysis pipeline
Design principles I build around: evaluation-first (no model ships without a regression gate), deterministic core with LLM only where humans disagree, and provenance as a first-class citizen.